Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Phase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1

    Recruiting

    3 1
    Investigated Drugs:
    Belgium France Italy The Netherlands Spain
  • Long-term Safety Study of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia Who Completed a Previous ORX750 Trial

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain
  • A Study to Test the Safety and Effectiveness of TAK-360 in People with Narcolepsy without Cataplexy

    Recruiting

    2 1
    France Italy Spain
  • Study on the Safety and Effects of ORX750 for Patients with Narcolepsy and Idiopathic Hypersomnia

    Recruiting

    2 1
    Investigated Drugs:
    France Italy Spain
  • Long-Term Study on the Safety and Effects of ALKS 2680 for Patients with Narcolepsy Type 1 and Type 2

    Recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Italy The Netherlands Spain
  • Study on the Long-term Safety of TAK-861 for Patients with Narcolepsy Type 1

    Recruiting

    4 1 1
    Investigated Diseases:
    Austria Belgium Finland France Germany Italy +5
  • Efficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1

    Not yet recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Finland France Germany Italy +5
  • Efficacy and Safety of E2086 in Adults with Narcolepsy: A Randomized, Double‑Blind, Placebo‑Controlled Trial

    Not yet recruiting

    2 1
    Investigated Diseases:
    Belgium Germany Italy Spain
  • A Randomized Double‑Blind Placebo‑Controlled Study of TAK‑360 in Adults with Narcolepsy with Cataplexy (Type 1)

    Not yet recruiting

    2 1
    France Italy Spain
  • Phase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2

    Not yet recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Italy The Netherlands Spain